Out-licensing
Up-to-date access to technology licensing opportunities worldwide.
- Out-licensing
- Browse
Licensing opportunities
Cripto-1 expression increases the expression of TNF-alpha in CD4+ T cells in tissues affected by chronic inflammatory disease. More
Rheumatoid arthritis More
These hybrid antibody molecules can be engineered with a variety of small synthetic molecules, and the combination of immunogenic properties results in compounds with powerful target destruction or imaging capabilities. More
MGD3 monoclonal antibody binds human Dectin-1 with high affinity and regulates production of cytokines TNF-α and Interleukin-10. MGD3 has a potential therapeutic use on inflammatory diseases. More
Peptide constructs that may be of clinical importance in HIV/AIDS vaccine development More
Compositions and methods for treating immune related disease More
Experiments confirm that RPS3 is essential for normal expression of specific NF-kappaB target genes, including key physiological events that require p65. More
Grb2 SH2 domain signaling antagonists with enhanced binding affinity. More
Novel peptides have been developed that are useful to induce Autoimmune Anterior Uveitis (AAU) and to treat symptoms associated with Anterior Uveitis. Additional potential uses for these peptides include identification of specific antigenic or uveitogeni More
Anti-CD79 Antibody Offers Novel Approach to Therapy in Autoimmune Disease, Transplantation and Lymphoma More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 399 pages - $1,495
Sep 2011 - 95 pages - $3,500
Nov 2010 - 933 pages - $1,495
Nov 2010 - 308 pages - $1,495
Nov 2010 - 330 pages - $1,495
Nov 2010 - 527 pages - $1,495
Aug 2011 - 58 pages - $5,700
Sep 2009 - 159 pages - $4,650
Sep 2011 - 87 pages - $5,700
Aug 2007 - 345 pages - $2,875
Your selection
Browse By
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us